HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,557,000 | +19.1% | 104,110 | +27.4% | 0.11% | +7.8% |
| Q4 2020 | $9,702,000 | +19.3% | 81,702 | -12.3% | 0.10% | +19.8% |
| Q3 2020 | $8,130,000 | -49.4% | 93,182 | -48.0% | 0.09% | -52.5% |
| Q2 2020 | $16,057,000 | +105.8% | 179,288 | +129.0% | 0.18% | +70.8% |
| Q1 2020 | $7,802,000 | -36.0% | 78,288 | -26.2% | 0.11% | -18.5% |
| Q4 2019 | $12,190,000 | -1.7% | 106,088 | +7.9% | 0.13% | -5.1% |
| Q3 2019 | $12,398,000 | -15.5% | 98,288 | -19.4% | 0.14% | -16.0% |
| Q2 2019 | $14,668,000 | +1.7% | 121,888 | -26.1% | 0.16% | +0.6% |
| Q1 2019 | $14,424,000 | -15.1% | 164,888 | -2.9% | 0.16% | -22.1% |
| Q4 2018 | $16,997,000 | -12.7% | 169,888 | 0.0% | 0.21% | +8.3% |
| Q3 2018 | $19,466,000 | +21.2% | 169,888 | -5.1% | 0.19% | +18.5% |
| Q2 2018 | $16,056,000 | -6.6% | 179,038 | -23.8% | 0.16% | -9.0% |
| Q1 2018 | $17,195,000 | +4.2% | 235,038 | -17.3% | 0.18% | +8.5% |
| Q4 2017 | $16,503,000 | – | 284,138 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |